Metformin Enhances the Therapy Effects of Anti-IGF-1R mAb Figitumumab to NSCLC

類似資料

• Combinational Therapy Enhances the Effects of Anti-IGF-1R mAb Figitumumab to Target Small Cell Lung Cancer
  著者:: Cao, Hongxin, 等
  出版事項: (2015)
• The adverse events profile of anti-IGF-1R monoclonal antibodies in cancer therapy
  著者:: Ma, Honghai, 等
  出版事項: (2014)
• Antitumor effects and molecular mechanisms of figitumumab, a humanized monoclonal antibody to IGF-1 receptor, in esophageal carcinoma
  著者:: Zhang, Tiehong, 等
  出版事項: (2014)
• Pharmacokinetic mAb–mAb Interaction: Anti-VEGF mAb Decreases the Distribution of Anti-CEA mAb into Colorectal Tumor Xenografts
  著者:: Abuqayyas, Lubna, 等
  出版事項: (2012)
• Association between Circulating Levels of IGF-1 and IGFBP-3 and Lung Cancer Risk: A Meta-Analysis
  著者:: Cao, Hongxin, 等
  出版事項: (2012)